Solid-state form of amg 706 and pharmaceutical compositions thereof ->
Monitor Keywords
*
Can't find it?
* Get
notified
when a new patent matches your "search terms".
More info...
Site News
|
Monitor Keywords
|
Monitor Archive
|
Organizer
|
Account Info
|
05/08/08
-
USPTO Class 514
| 268 views |
#20080108664
|
Prev
-
Next
|
About this Page
Solid-state form of amg 706 and pharmaceutical compositions thereof
Title:
Solid-state form of amg 706 and pharmaceutical compositions thereof
Brief Patent Description
-
Full Patent Description
-
Patent Claims
The Patent Description & Claims data below is from USPTO Patent Application 20080108664, Solid-state form of amg 706 and pharmaceutical compositions thereof.
1. An amorphous form of a compound wherein said compound is AMG706.
2. The amorphous form of claim 1, wherein said amorphous form exhibits a glass transition measurable by differential scanning calorimetry.
3. The amorphous form of claim 1 wherein said amorphous form exhibits a differential scanning calorimetry thermogram glass transition at about 110.degree. C.
4. The amorphous form of claim 1 wherein said amorphous form exhibits a differential scanning calorimetry thermogram exotherm between about 150.degree. C. to about 160.degree. C.
5. A pharmaceutical composition comprising amorphous AMG 706 in a total AMG 706 dosage amount of about 25 mg to about 200 mg, and one or more pharmaceutically acceptable excipients, wherein said amorphous AMG 706 exhibits a glass transition measurable by differential scanning calorimetry.
6. Amorphous AMG 706 prepared by a lyophilization method.
7. Amorphous AMG 706 prepared by a spray drying method.
Brief Patent Description
-
Full Patent Description
-
Patent Claims
Click on the above for other options relating to this Solid-state form of amg 706 and pharmaceutical compositions thereof patent application.
Patent Applications in related categories:
20090291981 -
5-lipoxygenase-activating protein inhibitor
- Described herein is the FLAP inhibitor 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxy-pyridin-3-yl)-benzyl]-5-(5-methyl-pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid, or a pharmaceutically acceptable salt thereof. Also described are methods of preparing the FLAP inhibitor, or a pharmaceutically acceptable salt thereof, including solvates, and polymorphs thereof. Also described herein are pharmaceutical compositions suitable for administration to a mammal that include the FLAP ...
###
How
KEYWORD MONITOR
works...
a
FREE
service from FreshPatents
1.
Sign up
(takes 30 seconds). 2.
Fill in the keywords
to be monitored.
3. Each week you receive an email with patent applications related to your keywords.
Start now!
- Receive info on patent apps like Solid-state form of amg 706 and pharmaceutical compositions thereof or other areas of interest.
###
Previous Patent Application:
Cyclopropyl piperidine glycine transporter inhibitors
Next Patent Application:
Heteroaryl (substituted)alkyl n-substituted sulfoximines as insecticides
Industry Class:
Drug, bio-affecting and body treating compositions
###
FreshPatents.com Support
Thank you for viewing the
Solid-state form of amg 706 and pharmaceutical compositions thereof
patent info.
IP-related news and info
Results in 0.30452 seconds
Other interesting Feshpatents.com categories:
Software:
Finance
,
AI
,
Databases
,
Development
,
Document
,
Navigation
,
Error
174
* Protect your Inventions
* US Patent Office filing
Provisional Patent
Utility Patent
PATENT INFO
What Is a Patent?
What Is a Trademark or Servicemark?
What Is a Copyright?
Patent Laws